| Mrs Gwennyth L Palafox, PHD | |
|
1001 S Marengo Ave, Pasadena, CA 91106-4207 | |
| (626) 795-4092 | |
| (626) 795-9505 |
| Full Name | Mrs Gwennyth L Palafox |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 1001 S Marengo Ave, Pasadena, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033463153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY20494 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Gwennyth L Palafox, PHD 1001 S Marengo Ave, Pasadena, CA 91106-4207 Ph: (626) 795-4092 | Mrs Gwennyth L Palafox, PHD 1001 S Marengo Ave, Pasadena, CA 91106-4207 Ph: (626) 795-4092 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.
Blood-contacting implantable medical devices, such as stents, heart valves, ventricular assist devices, and extracorporeal support systems, as well as vascular grafts and access catheters, are used worldwide to improve patients' lives. However, these devices are prone to failure due to the body's responses at the blood-material interface; clots can form and inflammatory reactions can prevent the device from performing as indicated. Currently, when this occurs, the only solution is to replace the device.
Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc., today announced the introduction of an imaging and visualization service for endovascular specialists who use the company's market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone and can rupture with fatal consequences if left untreated.
Amgen today announced results from a small, randomized, placebo-controlled Phase 2 study indicating that adding AMG 479 to gemcitabine improved overall survival at six months (primary endpoint) and progression-free survival in patients with metastatic pancreatic cancer. The study, which also included a separate arm of conatumumab plus gemcitabine, is being presented in a Poster Discussion at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting.
› Verified 2 days ago
Dr. Melissa Main Udell, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 988 S Fair Oaks Ave, Pasadena, CA 91105 Phone: 626-582-7980 | |
Dr. Louis Meaux, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 595 E Colorado Blvd, 406, Pasadena, CA 91101 Phone: 626-568-0852 | |
Dr. Duane Paul Alleman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 E Del Mar Blvd, Suite 122, Pasadena, CA 91105 Phone: 626-792-8922 Fax: 626-792-6504 | |
Jason Daniel Arkin, Psychologist Medicare: Medicare Enrolled Practice Location: 107 S Fair Oaks Ave Ste 325, Pasadena, CA 91105 Phone: 510-414-7366 | |
Dr. Adrienne Meier, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 130 S Euclid Ave, Pasadena, CA 91101 Phone: 949-441-0191 | |
Melissa Lynn Mcdaniel, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 960 E Green St Ste 203, Pasadena, CA 91106 Phone: 323-825-1973 | |
Dr. Suzanne Marie Lake, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2810 E Del Mar Blvd, Suite A, Pasadena, CA 91107 Phone: 626-795-8148 |